According to Prof. O’Neill, Ozempic could reduce the risk of heart attack and stroke by as much as 20%. “That would have a ...

Ozempic is advertised as a medication for those suffering with type 2 diabetes, but has reportedly been used by many to ...

We have hardly begun to understand how inextricably our own health and safety are intertwined with those of our wild ...

PHILADELPHIA — New research provides more evidence that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) do not increase the risk for pancreatic cancer. Instead, the large electronic health ...

Related Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction Weight-loss drugs can help stroke survivors prevent recurrence Weight-loss surgeries decline 25% as GLP-1 drugs ...

In the univariate analysis, those on an SGLT-2i/GLP-1 RA had a reduced risk for mortality, incident MI, and composite. (HealthDay News) — For patients with ischemic stroke, sodium-glucose ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community needs to figure out how to keep patients on the drugs long term to fully ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on ...

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.